RA 6675 Part 4

Question 1

Responsible Parenthood and Reproductive Health (RPRH) Act of 2012 and its IRR

Answer 1

RA 10354

Question 2

Rare Diseases Act of the Philippines

Answer 2

RA 20747

Question 3

National Integrated Cancer Control Act (NICCA)

Answer 3

RA 11215

Question 4

What Act gives all persons the right to choose and make decisions for themselves in accordance with their religious convictions, ethics, cultural beliefs, and the demands of responsible parenthood.

Answer 4

RA 10354

Question 5

T/F: The National Drug Formulary shall include hormonal contraceptives, intrauterine devices, injectables and other safe, legal, non-abortifacient and effective family planning products and supplies.

Answer 5

True

Question 6

What RA states:

The National Drug Formulary shall include hormonal contraceptives, intrauterine devices, injectables and other safe, legal, non-abortifacient and effective family planning products and supplies.

Answer 6

RA 10354

Question 7

_________________ shall be observed in selecting drugs including family planning supplies that will be included or removed from the Essential Drugs List (EDL) in accordance with existing practice and in consultation with reputable medical associations in the Philippines.

Answer 7

Philippine National Drug Formulary System (PNDFS)

Question 8

For the purpose of this Act (10354) , any product or supply included or to be included in the EDL must have a certification from the _________________ that said product and supply is made available on the condition that it is not to be used as an ___________.

Answer 8

FDA; abortifacient

Question 9

RA 10354 states that:

Pursuant to the herein declared policy, the ____________ shall serve as the lead agency for the implementation of this Act

Answer 9

DOH (in coordination with the PHIC)

Question 10

RA 10354 states that:

The __________ shall issue strict guidelines with respect to the use of contraceptives, taking into consideration the side effects or other harmful effects of their use

Answer 10

FDA

Question 11

RA 10354 penalties

Answer 11

1-6 months imprisonment and/or 10,000 - 100,000 fine

if public offcer:
nmt 1 year of suspension or removal or forfeiture of retirement

Question 12

An Act promulgating a comprehensive policy in addressing the needs of persons with rare disease

Answer 12

10747

Question 13

This RA provides regulatory and fiscal incentives to support research and development studies on rare diseases and to facilitate the manufacture and importation of affordable orphan drugs and orphan products

Answer 13

10747

Question 14

refers to any drug or medicine used to treat or alleviate the symptoms of persons afflicted with a rare disease and declared as such by the DOH upon recommendation of the National Institutes of Health (NIH).

Answer 14

Orphan drug

Question 15

refers to any healthcare or nutritional product, other than a drug or medicine, including, but not limited to, diagnostic kits, medical devices and biological products used to prevent, diagnose, or treat rare diseases and declared as such by the DOH upon recommendation of the NIH.

Answer 15

Orphan product

Question 16

refers to disorders such as inherited metabolic disorders and other diseases with similar rare occurrence as recognized by the DOH upon recommendation of the NIH but excluding catastrophic (i.e., life threatening, seriously debilitating, or serious and chronic) forms of more frequently occurring diseases.

Answer 16

Rare disease

Question 17

T/F: Persons with Rare Disease are accorded the same rights and privileges as PWDs in RA 10747

Answer 17

True

Question 18

shall
provide assistance to persons with rare disease to ensure that their social welfare and benefits provided under Republic Act No. 7277

Answer 18

Department of Social Welfare and Development (DSWD)

Question 19

Within ________________ from the effectivity of this Act, the DOH shall publish a list of orphan drugs for these rare diseases.

Answer 19

one hundred twenty (120) days

Question 20

Permit for Restricted Use of an Orphan Drug/Orphan Produc

Within __________ days from receipt of the requirements, the FDA shall issue a permit for restricted use of an orphan drug/orphan product which shall be effective for a period of _____________, renewable for a period of __________thereafter: Provided, That the FDA shall expedite the said permit in cases of emergency.

Answer 20

thirty (30); three (3) years; three (3) years

Question 21

This RA shall likewise make cancer treatment and care more equitable and affordable for all, especially for the underprivileged, poor and marginalized Filipinos.

Answer 21

11215

Question 22

___________ shall procure drugs and devices guided by price reference indices, following centrally negotiated prices, sell them following the prescribed maximum mark-ups, and submit to DOH a price list of all drugs and devices procured and sold by the health care provider.

Answer 22

DOH-owned health care providers

Question 23

An act institutionalising a national integrated cancer control program and appropriating funds therefor

Answer 23

11215

Question 24

___________ composed of representatives from the DOH, PhilHealth and the Department of Trade and Industry (DTI), among others, shall be constituted to negotiate prices on behalf of the DOH and PhilHealth, guided by certain parameters including new technology, innovator drugs, and sourced from a single supplier

Answer 24

An independent price negotiation board

Question 25

t/f: Drug outlets shall be required at all times to carry the generic equivalent of all drugs in the Primary Care Formulary and shall be required to provide customers with a list of therapeutic equivalents and then’ corresponding prices when fulfilling prescriptions or in any transaction.

Answer 25

True